Filed 4.8y ago· Aug 26, 2021
213 days to disclose · 168 past 45-day window
Tom Malinowski
—HouseNew Jersey-07
↑bought
Pacira Biosciences
PCRX
$1K-$15K
Trade dateJan 25, 2021
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.















| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | Jan 25, 2021 213 days to disclose · 168 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | A APPAD | Dec 30, 2020 239 days to disclose · 194 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Merck MRK Common Stock | Aug 26, 2020 365 days to disclose · 320 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Anika Therapeutics ANIK | Feb 28, 2020 545 days to disclose · 500 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Anika Therapeutics ANIK | Feb 27, 2020 546 days to disclose · 501 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | Anika Therapeutics ANIK | Jan 28, 2020 576 days to disclose · 531 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | Anika Therapeutics ANIK | Oct 29, 2019 667 days to disclose · 622 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Anika Therapeutics ANIK | Aug 1, 2019 756 days to disclose · 711 past 45-day window | price pending | $50K-$100K midpoint $75K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | Anika Therapeutics ANIK | Jul 29, 2019 759 days to disclose · 714 past 45-day window | price pending | $1K-$15K midpoint $8K |
Aug 26, 2021 4.8y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | May 31, 2019 818 days to disclose · 773 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 9, 2021 4.9y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | Merck MRK Common Stock | Nov 4, 2020 247 days to disclose · 202 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jul 9, 2021 4.9y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Merck MRK Common Stock | Aug 24, 2020 319 days to disclose · 274 past 45-day window | price pending | $15K-$50K midpoint $32.5K |
Jun 23, 2021 5.0y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↓sold | A APPAD Heron Therapeutics | May 18, 2021 36 days to disclose | price pending | $15K-$50K midpoint $32.5K |
Jun 23, 2021 5.0y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | May 6, 2021 48 days to disclose · 3 past 45-day window | Bad buy·−$4.9K-61.2% −131.5% vs S&P 500 | $1K-$15K midpoint $8K |
Jun 12, 2021 5.0y ago | ![]() Tom Malinowski —HouseNew Jersey-07 | ↑bought | Pacira Biosciences PCRX | Apr 20, 2021 53 days to disclose · 8 past 45-day window | price pending | $1K-$15K midpoint $8K |